Clinical Trials Details

NRG-BR004 (Breast)

A Randomized, Double-Blind, Phase III trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in first-line HER2 positive Metastatic breast cancer

Objective

» Learn more about the trial

Clinical Trial Categories

  • Cancers and Other Neoplasms